Unknown

Dataset Information

0

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.


ABSTRACT: PURPOSE:Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which includes numbness, tingling, pain, cold sensitivity, and motor impairment in the hands and feet. CIPN is a dose-limiting toxicity, potentially increasing mortality. There are no FDA-approved drugs to treat CIPN, and behavioral interventions such as exercise are promising yet understudied. This secondary analysis of our nationwide phase III randomized controlled trial of exercise for fatigue examines (1) effects of exercise on CIPN symptoms, (2) factors that predict CIPN symptoms, and (3) factors that moderate effects of exercise on CIPN symptoms. METHODS:Cancer patients (N?=?355, 56?±?11 years, 93% female, 79% breast cancer) receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy were randomized to chemotherapy or chemotherapy plus Exercise for Cancer Patients (EXCAP©®). EXCAP is a standardized, individualized, moderate-intensity, home-based, six-week progressive walking and resistance exercise program. Patients reported CIPN symptoms of numbness and tingling and hot/coldness in hands/feet (0-10 scales) pre- and post-intervention. We explored baseline neuropathy, sex, age, body mass index, cancer stage, and cancer type as possible factors associated with CIPN symptoms and exercise effectiveness. RESULTS:Exercise reduced CIPN symptoms of hot/coldness in hands/feet (-0.46 units, p?=?0.045) and numbness and tingling (-?0.42 units, p?=?0.061) compared to the control. Exercise reduced CIPN symptoms more for patients who were older (p?=?0.086), male (p?=?0.028), or had breast cancer (p?=?0.076). CONCLUSIONS:Exercise appears to reduce CIPN symptoms in patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy. Clinicians should consider prescribing exercise for these patients. TRIAL REGISTRATION:Clinical Trials.gov , # NCT00924651, http://www.clinicaltrials.gov .

SUBMITTER: Kleckner IR 

PROVIDER: S-EPMC5823751 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Kleckner Ian R IR   Kamen Charles C   Gewandter Jennifer S JS   Mohile Nimish A NA   Heckler Charles E CE   Culakova Eva E   Fung Chunkit C   Janelsins Michelle C MC   Asare Matthew M   Lin Po-Ju PJ   Reddy Pavan S PS   Giguere Jeffrey J   Berenberg Jeffrey J   Kesler Shelli R SR   Mustian Karen M KM  

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20171214 4


<h4>Purpose</h4>Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which includes numbness, tingling, pain, cold sensitivity, and motor impairment in the hands and feet. CIPN is a dose-limiting toxicity, potentially increasing mortality. There are no FDA-approved drugs to treat CIPN, and behavioral interventions such as exercise are promising yet understudied. This secondary analysis of  ...[more]

Similar Datasets

| S-EPMC7666827 | biostudies-literature
| S-EPMC8442518 | biostudies-literature
| S-EPMC10813204 | biostudies-literature
| S-EPMC7160396 | biostudies-literature
| S-EPMC8476560 | biostudies-literature
| S-EPMC8397157 | biostudies-literature
| S-EPMC8030600 | biostudies-literature
| S-EPMC5009142 | biostudies-literature
| S-EPMC8935622 | biostudies-literature
| S-EPMC10283240 | biostudies-literature